This corporate video conveys our VISION to turning innovative science into VALUE for patients, and introduces Astellas to our stakeholders...
Astellas Pharma Inc.
103,001 million yen (March 2019)
Kenji Yasukawa (President and Chief Executive Officer)
16,243 (Consolidated basis, March 2019)
Manufacturing, marketing and import/export of pharmaceuticals.